HBeAg 阴性患者分离株的 HBsAg 释放和抗增殖/抗氧化细胞调节能力受损反映了一个进化过程。

IF 6 2区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Liver International Pub Date : 2024-07-30 DOI:10.1111/liv.16048
Michael Basic, Keerthihan Thiyagarajah, Mirco Glitscher, Anja Schollmeier, Qingyan Wu, Esra Görgülü, Pia Lembeck, Jannik Sonnenberg, Julia Dietz, Fabian Finkelmeier, Michael Praktiknjo, Jonel Trebicka, Stefan Zeuzem, Christoph Sarrazin, Eberhard Hildt, Kai-Henrik Peiffer
{"title":"HBeAg 阴性患者分离株的 HBsAg 释放和抗增殖/抗氧化细胞调节能力受损反映了一个进化过程。","authors":"Michael Basic,&nbsp;Keerthihan Thiyagarajah,&nbsp;Mirco Glitscher,&nbsp;Anja Schollmeier,&nbsp;Qingyan Wu,&nbsp;Esra Görgülü,&nbsp;Pia Lembeck,&nbsp;Jannik Sonnenberg,&nbsp;Julia Dietz,&nbsp;Fabian Finkelmeier,&nbsp;Michael Praktiknjo,&nbsp;Jonel Trebicka,&nbsp;Stefan Zeuzem,&nbsp;Christoph Sarrazin,&nbsp;Eberhard Hildt,&nbsp;Kai-Henrik Peiffer","doi":"10.1111/liv.16048","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Background</h3>\n \n <p>The hepatitis B e antigen (HBeAg)-negative infection Phase 3 is characterized by no or minimal signs of hepatic inflammation and the absence of hepatic fibrosis. However, underlying molecular mechanisms leading to this benign phenotype are poorly understood.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>Genotype A, B and D HBeAg-negative patient isolates with precore mutation G1896A from Phase 3 were analysed in comparison with respective HBeAg-positive rescue mutant and HBeAg-positive wild-type reference genomes regarding differences in viral replication, morphogenesis, infectivity and impact on NF-E2-related factor 2 (Nrf2)/antioxidant response element (ARE)-dependent gene expression and cellular kinome.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>In comparison with reference genomes, the patient isolates are characterized by a lower intra- and extracellular hepatitis B surface antigen (HBsAg)-amount, and HBsAg-retention in the endoplasmic reticulum. Rescue of HBeAg expression increased HBsAg-amount but not its release. Expression of the isolated genomes is associated with a higher Nrf2/ARE-dependent gene expression as compared to reference genomes independent of HBeAg expression. Kinome analyses revealed a decreased activity of receptors involved in regulation of proliferative pathways for all patient isolates compared to the reference genomes. No specific conserved mutations could be found between all genomes from Phase 3.</p>\n </section>\n \n <section>\n \n <h3> Conclusions</h3>\n \n <p>HBeAg-negative genomes from Phase 3 exhibit distinct molecular characteristics leading to lower HBsAg synthesis and release, enhanced oxidative stress protection and decreased activity of key kinases, triggering an antiproliferative stage, which might contribute to the lower probability of hepatocellular carcinoma. The observed differences cannot be associated with loss of HBeAg or specific mutations common to all analysed isolates, indicating the phenotype of Phase 3 derived genomes to be the result of a multifactorial process likely reflecting a conserved natural selection process.</p>\n </section>\n </div>","PeriodicalId":18101,"journal":{"name":"Liver International","volume":null,"pages":null},"PeriodicalIF":6.0000,"publicationDate":"2024-07-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/liv.16048","citationCount":"0","resultStr":"{\"title\":\"Impaired HBsAg release and antiproliferative/antioxidant cell regulation by HBeAg-negative patient isolates reflects an evolutionary process\",\"authors\":\"Michael Basic,&nbsp;Keerthihan Thiyagarajah,&nbsp;Mirco Glitscher,&nbsp;Anja Schollmeier,&nbsp;Qingyan Wu,&nbsp;Esra Görgülü,&nbsp;Pia Lembeck,&nbsp;Jannik Sonnenberg,&nbsp;Julia Dietz,&nbsp;Fabian Finkelmeier,&nbsp;Michael Praktiknjo,&nbsp;Jonel Trebicka,&nbsp;Stefan Zeuzem,&nbsp;Christoph Sarrazin,&nbsp;Eberhard Hildt,&nbsp;Kai-Henrik Peiffer\",\"doi\":\"10.1111/liv.16048\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div>\\n \\n \\n <section>\\n \\n <h3> Background</h3>\\n \\n <p>The hepatitis B e antigen (HBeAg)-negative infection Phase 3 is characterized by no or minimal signs of hepatic inflammation and the absence of hepatic fibrosis. However, underlying molecular mechanisms leading to this benign phenotype are poorly understood.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Methods</h3>\\n \\n <p>Genotype A, B and D HBeAg-negative patient isolates with precore mutation G1896A from Phase 3 were analysed in comparison with respective HBeAg-positive rescue mutant and HBeAg-positive wild-type reference genomes regarding differences in viral replication, morphogenesis, infectivity and impact on NF-E2-related factor 2 (Nrf2)/antioxidant response element (ARE)-dependent gene expression and cellular kinome.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Results</h3>\\n \\n <p>In comparison with reference genomes, the patient isolates are characterized by a lower intra- and extracellular hepatitis B surface antigen (HBsAg)-amount, and HBsAg-retention in the endoplasmic reticulum. Rescue of HBeAg expression increased HBsAg-amount but not its release. Expression of the isolated genomes is associated with a higher Nrf2/ARE-dependent gene expression as compared to reference genomes independent of HBeAg expression. Kinome analyses revealed a decreased activity of receptors involved in regulation of proliferative pathways for all patient isolates compared to the reference genomes. No specific conserved mutations could be found between all genomes from Phase 3.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Conclusions</h3>\\n \\n <p>HBeAg-negative genomes from Phase 3 exhibit distinct molecular characteristics leading to lower HBsAg synthesis and release, enhanced oxidative stress protection and decreased activity of key kinases, triggering an antiproliferative stage, which might contribute to the lower probability of hepatocellular carcinoma. The observed differences cannot be associated with loss of HBeAg or specific mutations common to all analysed isolates, indicating the phenotype of Phase 3 derived genomes to be the result of a multifactorial process likely reflecting a conserved natural selection process.</p>\\n </section>\\n </div>\",\"PeriodicalId\":18101,\"journal\":{\"name\":\"Liver International\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":6.0000,\"publicationDate\":\"2024-07-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1111/liv.16048\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Liver International\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1111/liv.16048\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"GASTROENTEROLOGY & HEPATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Liver International","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/liv.16048","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

背景:乙型肝炎 e 抗原(HBeAg)阴性感染 3 期的特点是没有或极少出现肝脏炎症和肝纤维化。然而,人们对导致这种良性表型的潜在分子机制知之甚少:方法:研究人员将第三阶段中带有前核突变 G1896A 的基因型 A、B 和 D HBeAg 阴性患者分离株与各自的 HBeAg 阳性拯救突变株和 HBeAg 阳性野生型参考基因组进行了比较分析,研究病毒复制、形态发生、感染性以及对 NF-E2 相关因子 2(Nrf2)/抗氧化反应元件(ARE)依赖性基因表达和细胞动力学组的影响等方面的差异:结果:与参考基因组相比,患者分离物的特点是细胞内和细胞外乙肝表面抗原(HBsAg)含量较低,HBsAg保留在内质网中。拯救 HBeAg 的表达会增加 HBsAg 的数量,但不会增加其释放。与独立于 HBeAg 表达的参考基因组相比,分离基因组的表达与较高的 Nrf2/ARE 依赖性基因表达有关。基因组分析表明,与参考基因组相比,所有患者分离基因组中参与增殖途径调控的受体活性均有所下降。第三阶段的所有基因组之间没有发现特定的保守突变:结论:第 3 阶段的 HBeAg 阴性基因组表现出明显的分子特征,导致 HBsAg 合成和释放降低、氧化应激保护增强、关键激酶活性降低,从而引发抗增殖阶段,这可能是导致肝细胞癌发生概率降低的原因。观察到的差异与 HBeAg 缺失或所有分析分离物共有的特定突变无关,这表明第 3 阶段衍生基因组的表型是一个多因素过程的结果,很可能反映了一个保守的自然选择过程。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Impaired HBsAg release and antiproliferative/antioxidant cell regulation by HBeAg-negative patient isolates reflects an evolutionary process

Background

The hepatitis B e antigen (HBeAg)-negative infection Phase 3 is characterized by no or minimal signs of hepatic inflammation and the absence of hepatic fibrosis. However, underlying molecular mechanisms leading to this benign phenotype are poorly understood.

Methods

Genotype A, B and D HBeAg-negative patient isolates with precore mutation G1896A from Phase 3 were analysed in comparison with respective HBeAg-positive rescue mutant and HBeAg-positive wild-type reference genomes regarding differences in viral replication, morphogenesis, infectivity and impact on NF-E2-related factor 2 (Nrf2)/antioxidant response element (ARE)-dependent gene expression and cellular kinome.

Results

In comparison with reference genomes, the patient isolates are characterized by a lower intra- and extracellular hepatitis B surface antigen (HBsAg)-amount, and HBsAg-retention in the endoplasmic reticulum. Rescue of HBeAg expression increased HBsAg-amount but not its release. Expression of the isolated genomes is associated with a higher Nrf2/ARE-dependent gene expression as compared to reference genomes independent of HBeAg expression. Kinome analyses revealed a decreased activity of receptors involved in regulation of proliferative pathways for all patient isolates compared to the reference genomes. No specific conserved mutations could be found between all genomes from Phase 3.

Conclusions

HBeAg-negative genomes from Phase 3 exhibit distinct molecular characteristics leading to lower HBsAg synthesis and release, enhanced oxidative stress protection and decreased activity of key kinases, triggering an antiproliferative stage, which might contribute to the lower probability of hepatocellular carcinoma. The observed differences cannot be associated with loss of HBeAg or specific mutations common to all analysed isolates, indicating the phenotype of Phase 3 derived genomes to be the result of a multifactorial process likely reflecting a conserved natural selection process.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Liver International
Liver International 医学-胃肠肝病学
CiteScore
13.90
自引率
4.50%
发文量
348
审稿时长
2 months
期刊介绍: Liver International promotes all aspects of the science of hepatology from basic research to applied clinical studies. Providing an international forum for the publication of high-quality original research in hepatology, it is an essential resource for everyone working on normal and abnormal structure and function in the liver and its constituent cells, including clinicians and basic scientists involved in the multi-disciplinary field of hepatology. The journal welcomes articles from all fields of hepatology, which may be published as original articles, brief definitive reports, reviews, mini-reviews, images in hepatology and letters to the Editor.
期刊最新文献
Correction to "Erythropoietic protoporphyrias: Pathogenesis, diagnosis and management". Interpreting elevated liver blood test results through a genetic lens: A genome-wide association study. The Relationship Between Ferroptosis and Metabolic Dysfunction-Associated Fatty Liver Disease. Association of Liver Disease and Chronic Pruritus: A Case-Control Study. Impact of Direct-Acting Antiviral Therapy on All-Cause Mortality in Chronic Hepatitis C Patients.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1